Carlos Buesa, Oryzon’s Co-Founder, President and Chief Executive Officer commented, " The success of this capital raise is affirmation that investors , some of them specialized in the epigenetics
3i Group plc (“3i” or “3i Group”), an international investor, ...
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - NewCo Professional S.L. All Rights Reserved.